Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Main Index

View All
sD
second primary malignancies (SPM) Answer 14.2 Question 14.2
selective estrogen receptor degrader (SERD) Hormonal Agents and Combinations for Prevention and Treatment of ER Structures of Antiestrogenic Molecules Selective Estrogen Receptor Degrader (SERD)
selective estrogen receptor modulators (SERMs) Hormonal Therapies Alone and in Combinations for Treatment of Breast Cancer Estrogen-Dependent Tumor Growth
selective serotonin reuptake inhibitors (SSRIs)
SERMs
SH
signal transducer and activator of transcription (STAT)
sinusoidal obstruction syndrome (SOS)
SLAM
SMAC
Small molecules, targeted therapies
SPEP
SQ
stable disease (SD)
stem cell transplantation (SCT) Question 15.1 Question 15.3 Question 15.5 Question 15.2 Question 15.4 Transplant-Related Agents
Stevens-Johnson syndrome (SJS)
sulfhydryl (SH)
SCT
second mitochondrial activator of caspases (SMAC)
selective inhibitors of nuclear export (SINE)
SERD
serum protein electrophoresis (SPEP)
signaling lymphocytic activation molecule (SLAM)
SINE
SJS
SLL
small lymphocytic lymphoma (SLL)
SOS
SPM